01 - Articolo su rivista

01 - Articolo su rivista: [79581] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.461 a 7.480 di 79.581

HIV phylogenetics

2007-01-01 Pillay, D; Rambaut, A; Geretti, Am; Brown, Ajl

Science in court: The myth of HIV fingerprinting

2011-01-01 Abecasis, Ab; Geretti, Am; Albert, J; Power, L; Weait, M; Vandamme, A-

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)

2006-01-01 Gazzard, B; Bernard, Ej; Boffito, M; Churchill, D; Edwards, S; Fisher, M; Geretti, Am; Johnson, M; Leen, C; Peters, B; Pozniak, A; Ross, J; Walsh, J; Wilkins, E; Youle, M

Immunization of the HIV infected traveller

2007-01-01 Chadwick, Dr; Geretti, Am

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: Multicentre observational study

2012-01-01 Dolling, D; Sabin, C; Delpech, V; Smit, E; Pozniak, A; Asboe, D; Brown, Al; Churchill, D; Williams, I; Geretti, Am; Phillips, A; Mackie, N; Murphy, G; Castro, H; Pillay, D; Cane, P; Dunn, D

Comparative evaluation of the ExaVir load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load

2009-01-01 Labbett, W; Garcia-Diaz, A; Fox, Z; Clewley, Gs; Fernandez, T; Johnson, M; Geretti, Am

Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes

2001-01-01 Geretti, Am; Osterhaus, Adme

Herpes simplex virus type 2: Epidemiology and management options in developing countries

2007-01-01 Paz-Bailey, G; Ramaswamy, M; Hawkes, Sj; Geretti, Am

Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing

2011-01-01 D(')Aquila, Rt; Geretti, Am; Horton, Jh; Rouse, E; Kheshti, A; Raffanti, S; Oie, K; Pappa, K; Ross, Ll

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

2013-01-01 Mackie, Ne; Dunn, Dt; Dolling, D; Garvey, L; Harrison, L; Fearnhill, E; Tilston, P; Sabin, C; Geretti, Am

Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphism

2008-01-01 Garcia-Diaz, A; Blok, C; Madge, S; Booth, C; Tyrer, M; Bonora, S; Mahungu, T; Owen, A; Johnson, M; Geretti, Am

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients

2004-01-01 Mattes, Fm; Hainsworth, Eg; Geretti, Am; Nebbia, G; Prentice, G; Potter, M; Burroughs, Ak; Sweny, P; Hassan-Walker, Af; Okwuadi, S; Sabin, C; Amooty, G; Brown, Vs; Grace, Sc; Emery, Vc; Griffiths, Pd

Understanding protease inhibitor resistance - Aiming for the long term in treatment-experienced patients

2009-01-01 Geretti, Am

Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients - Impact of HIV subtypes and prior raltegravir experience

2011-01-01 Garrido, C; Soriano, V; Geretti, Am; Zahonero, N; Garcia, S; Booth, C; Gutierrez, F; Viciana, I; de Mendoza, C

Immunization for HIV-positive individuals

2010-01-01 Geretti, Am; Doyle, T

The effect of transmitted HIV-1 drug resistance on pre-therapy viral load

2010-01-01 Harrison, L; Castro, H; Cane, P; Pillay, D; Booth, C; Phillips, A; Geretti, Am; Dunn, D

Ongoing changes in HIV RNA levels during untreated HIV infection: Implications for CD4 cell count depletion

2010-01-01 Phillips, An; Lampe, Fc; Smith, Cj; Geretti, Am; Rodger, A; Lodwick, Rk; Cambiano, V; Tsintas, R; Johnson, Ma

Comparative evaluation of the performance of the abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation

2006-01-01 Garcia-Diaz, A; Clewley, Gs; Booth, Cl; Labett, W; Mcallister, N; Geretti, Am

Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

2011-01-01 Verhofstede, C; Brudney, D; Reynaerts, J; Vaira, D; Fransen, K; De Bel, A; Seguin-Devaux, C; De Wit, S; Vandekerckhove, L; Geretti, Am

The impact of transmitted drug-resistance on treatment selection and outcome of first-line highly active antiretroviral therapy (HAART)

2010-01-01 Bansi, L; Geretti, Am; Dunn, D; Hill, T; Green, H; Fearnhill, E; Gazzard, B; Nelson, M; Porter, K; Phillips, A; Sabin, C

Data di pubblicazione	Titolo	Autore(i)	Tipo
1-gen-2007	HIV phylogenetics	Pillay, D; Rambaut, A; Geretti, Am; Brown, Ajl	Articolo su rivista
1-gen-2011	Science in court: The myth of HIV fingerprinting	Abecasis, Ab; Geretti, Am; Albert, J; Power, L; Weait, M; Vandamme, A-	Articolo su rivista
1-gen-2006	British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)	Gazzard, B; Bernard, Ej; Boffito, M; Churchill, D; Edwards, S; Fisher, M; Geretti, Am; Johnson, M; Leen, C; Peters, B; Pozniak, A; Ross, J; Walsh, J; Wilkins, E; Youle, M	Articolo su rivista
1-gen-2007	Immunization of the HIV infected traveller	Chadwick, Dr; Geretti, Am	Articolo su rivista
1-gen-2012	Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: Multicentre observational study	Dolling, D; Sabin, C; Delpech, V; Smit, E; Pozniak, A; Asboe, D; Brown, Al; Churchill, D; Williams, I; Geretti, Am; Phillips, A; Mackie, N; Murphy, G; Castro, H; Pillay, D; Cane, P; Dunn, D	Articolo su rivista
1-gen-2009	Comparative evaluation of the ExaVir load version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load	Labbett, W; Garcia-Diaz, A; Fox, Z; Clewley, Gs; Fernandez, T; Johnson, M; Geretti, Am	Articolo su rivista
1-gen-2001	Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes	Geretti, Am; Osterhaus, Adme	Articolo su rivista
1-gen-2007	Herpes simplex virus type 2: Epidemiology and management options in developing countries	Paz-Bailey, G; Ramaswamy, M; Hawkes, Sj; Geretti, Am	Articolo su rivista
1-gen-2011	Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing	D(')Aquila, Rt; Geretti, Am; Horton, Jh; Rouse, E; Kheshti, A; Raffanti, S; Oie, K; Pappa, K; Ross, Ll	Articolo su rivista
1-gen-2013	The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults	Mackie, Ne; Dunn, Dt; Dolling, D; Garvey, L; Harrison, L; Fearnhill, E; Tilston, P; Sabin, C; Geretti, Am	Articolo su rivista
1-gen-2008	Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphism	Garcia-Diaz, A; Blok, C; Madge, S; Booth, C; Tyrer, M; Bonora, S; Mahungu, T; Owen, A; Johnson, M; Geretti, Am	Articolo su rivista
1-gen-2004	A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients	Mattes, Fm; Hainsworth, Eg; Geretti, Am; Nebbia, G; Prentice, G; Potter, M; Burroughs, Ak; Sweny, P; Hassan-Walker, Af; Okwuadi, S; Sabin, C; Amooty, G; Brown, Vs; Grace, Sc; Emery, Vc; Griffiths, Pd	Articolo su rivista
1-gen-2009	Understanding protease inhibitor resistance - Aiming for the long term in treatment-experienced patients	Geretti, Am	Articolo su rivista
1-gen-2011	Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients - Impact of HIV subtypes and prior raltegravir experience	Garrido, C; Soriano, V; Geretti, Am; Zahonero, N; Garcia, S; Booth, C; Gutierrez, F; Viciana, I; de Mendoza, C	Articolo su rivista
1-gen-2010	Immunization for HIV-positive individuals	Geretti, Am; Doyle, T	Articolo su rivista
1-gen-2010	The effect of transmitted HIV-1 drug resistance on pre-therapy viral load	Harrison, L; Castro, H; Cane, P; Pillay, D; Booth, C; Phillips, A; Geretti, Am; Dunn, D	Articolo su rivista
1-gen-2010	Ongoing changes in HIV RNA levels during untreated HIV infection: Implications for CD4 cell count depletion	Phillips, An; Lampe, Fc; Smith, Cj; Geretti, Am; Rodger, A; Lodwick, Rk; Cambiano, V; Tsintas, R; Johnson, Ma	Articolo su rivista
1-gen-2006	Comparative evaluation of the performance of the abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation	Garcia-Diaz, A; Clewley, Gs; Booth, Cl; Labett, W; Mcallister, N; Geretti, Am	Articolo su rivista
1-gen-2011	Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA	Verhofstede, C; Brudney, D; Reynaerts, J; Vaira, D; Fransen, K; De Bel, A; Seguin-Devaux, C; De Wit, S; Vandekerckhove, L; Geretti, Am	Articolo su rivista
1-gen-2010	The impact of transmitted drug-resistance on treatment selection and outcome of first-line highly active antiretroviral therapy (HAART)	Bansi, L; Geretti, Am; Dunn, D; Hill, T; Green, H; Fearnhill, E; Gazzard, B; Nelson, M; Porter, K; Phillips, A; Sabin, C	Articolo su rivista

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.461 a 7.480 di 79.581

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext43018
restricted19103
open16848
reserved362
partially open211
embargoed28
mixed10